Production (Stage)
NuGen Medical Devices Inc.
NGMDF
$0.043
$0.042942,900.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -72.59% | -23.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -72.59% | -23.83% | |||
| Cost of Revenue | -73.29% | -31.23% | |||
| Gross Profit | -72.00% | -16.17% | |||
| SG&A Expenses | -22.06% | -59.31% | |||
| Depreciation & Amortization | -2.83% | -0.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.28% | -53.06% | |||
| Operating Income | 5.60% | 60.35% | |||
| Income Before Tax | 202.35% | 116.73% | |||
| Income Tax Expenses | 196.43% | -135.44% | |||
| Earnings from Continuing Operations | 199.29% | 116.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 199.29% | 116.80% | |||
| EBIT | 5.60% | 60.35% | |||
| EBITDA | 6.21% | 65.02% | |||
| EPS Basic | 182.35% | 117.00% | |||
| Normalized Basic EPS | 314.29% | 77.42% | |||
| EPS Diluted | 182.35% | 117.00% | |||
| Normalized Diluted EPS | 314.29% | 77.42% | |||
| Average Basic Shares Outstanding | 3.20% | 0.99% | |||
| Average Diluted Shares Outstanding | 3.20% | 0.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||